The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral TYK2 Inhibitor Market Research Report 2025
Synopsis
The global Oral TYK2 Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oral TYK2 Inhibitor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral TYK2 Inhibitor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oral TYK2 Inhibitor in Psoriasis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oral TYK2 Inhibitor include Bristol-Myers Squibb, InnoCare Pharma, Takeda (Nimbus Therapeutics), E-nitiate Biopharmaceuticals, Highlightll Pharmaceutical, Pfizer, Alumis Inc., Galapagos NV and Ventyx Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral TYK2 Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral TYK2 Inhibitor.
Report Scope
The Oral TYK2 Inhibitor market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral TYK2 Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral TYK2 Inhibitor companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
InnoCare Pharma
Takeda (Nimbus Therapeutics)
E-nitiate Biopharmaceuticals
Highlightll Pharmaceutical
Pfizer
Alumis Inc.
Galapagos NV
Ventyx Biosciences
Segment by Type
Single-target Inhibitor
Dual-target Inhibitor
Segment by Application
Psoriasis
Atopic Dermatitis
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral TYK2 Inhibitor companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Oral TYK2 Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oral TYK2 Inhibitor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral TYK2 Inhibitor is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oral TYK2 Inhibitor in Psoriasis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oral TYK2 Inhibitor include Bristol-Myers Squibb, InnoCare Pharma, Takeda (Nimbus Therapeutics), E-nitiate Biopharmaceuticals, Highlightll Pharmaceutical, Pfizer, Alumis Inc., Galapagos NV and Ventyx Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral TYK2 Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral TYK2 Inhibitor.
Report Scope
The Oral TYK2 Inhibitor market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral TYK2 Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral TYK2 Inhibitor companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
InnoCare Pharma
Takeda (Nimbus Therapeutics)
E-nitiate Biopharmaceuticals
Highlightll Pharmaceutical
Pfizer
Alumis Inc.
Galapagos NV
Ventyx Biosciences
Segment by Type
Single-target Inhibitor
Dual-target Inhibitor
Segment by Application
Psoriasis
Atopic Dermatitis
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral TYK2 Inhibitor companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral TYK2 Inhibitor Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Single-target Inhibitor
1.2.3 Dual-target Inhibitor
1.3 Market by Application
1.3.1 Global Oral TYK2 Inhibitor Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Psoriasis
1.3.3 Atopic Dermatitis
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral TYK2 Inhibitor Market Perspective (2019-2030)
2.2 Oral TYK2 Inhibitor Growth Trends by Region
2.2.1 Global Oral TYK2 Inhibitor Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oral TYK2 Inhibitor Historic Market Size by Region (2019-2024)
2.2.3 Oral TYK2 Inhibitor Forecasted Market Size by Region (2025-2030)
2.3 Oral TYK2 Inhibitor Market Dynamics
2.3.1 Oral TYK2 Inhibitor Industry Trends
2.3.2 Oral TYK2 Inhibitor Market Drivers
2.3.3 Oral TYK2 Inhibitor Market Challenges
2.3.4 Oral TYK2 Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral TYK2 Inhibitor Players by Revenue
3.1.1 Global Top Oral TYK2 Inhibitor Players by Revenue (2019-2024)
3.1.2 Global Oral TYK2 Inhibitor Revenue Market Share by Players (2019-2024)
3.2 Global Oral TYK2 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral TYK2 Inhibitor Revenue
3.4 Global Oral TYK2 Inhibitor Market Concentration Ratio
3.4.1 Global Oral TYK2 Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral TYK2 Inhibitor Revenue in 2023
3.5 Oral TYK2 Inhibitor Key Players Head office and Area Served
3.6 Key Players Oral TYK2 Inhibitor Product Solution and Service
3.7 Date of Enter into Oral TYK2 Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral TYK2 Inhibitor Breakdown Data by Type
4.1 Global Oral TYK2 Inhibitor Historic Market Size by Type (2019-2024)
4.2 Global Oral TYK2 Inhibitor Forecasted Market Size by Type (2025-2030)
5 Oral TYK2 Inhibitor Breakdown Data by Application
5.1 Global Oral TYK2 Inhibitor Historic Market Size by Application (2019-2024)
5.2 Global Oral TYK2 Inhibitor Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oral TYK2 Inhibitor Market Size (2019-2030)
6.2 North America Oral TYK2 Inhibitor Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oral TYK2 Inhibitor Market Size by Country (2019-2024)
6.4 North America Oral TYK2 Inhibitor Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral TYK2 Inhibitor Market Size (2019-2030)
7.2 Europe Oral TYK2 Inhibitor Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oral TYK2 Inhibitor Market Size by Country (2019-2024)
7.4 Europe Oral TYK2 Inhibitor Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral TYK2 Inhibitor Market Size (2019-2030)
8.2 Asia-Pacific Oral TYK2 Inhibitor Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oral TYK2 Inhibitor Market Size by Region (2019-2024)
8.4 Asia-Pacific Oral TYK2 Inhibitor Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral TYK2 Inhibitor Market Size (2019-2030)
9.2 Latin America Oral TYK2 Inhibitor Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oral TYK2 Inhibitor Market Size by Country (2019-2024)
9.4 Latin America Oral TYK2 Inhibitor Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral TYK2 Inhibitor Market Size (2019-2030)
10.2 Middle East & Africa Oral TYK2 Inhibitor Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oral TYK2 Inhibitor Market Size by Country (2019-2024)
10.4 Middle East & Africa Oral TYK2 Inhibitor Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Detail
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Oral TYK2 Inhibitor Introduction
11.1.4 Bristol-Myers Squibb Revenue in Oral TYK2 Inhibitor Business (2019-2024)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 InnoCare Pharma
11.2.1 InnoCare Pharma Company Detail
11.2.2 InnoCare Pharma Business Overview
11.2.3 InnoCare Pharma Oral TYK2 Inhibitor Introduction
11.2.4 InnoCare Pharma Revenue in Oral TYK2 Inhibitor Business (2019-2024)
11.2.5 InnoCare Pharma Recent Development
11.3 Takeda (Nimbus Therapeutics)
11.3.1 Takeda (Nimbus Therapeutics) Company Detail
11.3.2 Takeda (Nimbus Therapeutics) Business Overview
11.3.3 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Introduction
11.3.4 Takeda (Nimbus Therapeutics) Revenue in Oral TYK2 Inhibitor Business (2019-2024)
11.3.5 Takeda (Nimbus Therapeutics) Recent Development
11.4 E-nitiate Biopharmaceuticals
11.4.1 E-nitiate Biopharmaceuticals Company Detail
11.4.2 E-nitiate Biopharmaceuticals Business Overview
11.4.3 E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Introduction
11.4.4 E-nitiate Biopharmaceuticals Revenue in Oral TYK2 Inhibitor Business (2019-2024)
11.4.5 E-nitiate Biopharmaceuticals Recent Development
11.5 Highlightll Pharmaceutical
11.5.1 Highlightll Pharmaceutical Company Detail
11.5.2 Highlightll Pharmaceutical Business Overview
11.5.3 Highlightll Pharmaceutical Oral TYK2 Inhibitor Introduction
11.5.4 Highlightll Pharmaceutical Revenue in Oral TYK2 Inhibitor Business (2019-2024)
11.5.5 Highlightll Pharmaceutical Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Oral TYK2 Inhibitor Introduction
11.6.4 Pfizer Revenue in Oral TYK2 Inhibitor Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Alumis Inc.
11.7.1 Alumis Inc. Company Detail
11.7.2 Alumis Inc. Business Overview
11.7.3 Alumis Inc. Oral TYK2 Inhibitor Introduction
11.7.4 Alumis Inc. Revenue in Oral TYK2 Inhibitor Business (2019-2024)
11.7.5 Alumis Inc. Recent Development
11.8 Galapagos NV
11.8.1 Galapagos NV Company Detail
11.8.2 Galapagos NV Business Overview
11.8.3 Galapagos NV Oral TYK2 Inhibitor Introduction
11.8.4 Galapagos NV Revenue in Oral TYK2 Inhibitor Business (2019-2024)
11.8.5 Galapagos NV Recent Development
11.9 Ventyx Biosciences
11.9.1 Ventyx Biosciences Company Detail
11.9.2 Ventyx Biosciences Business Overview
11.9.3 Ventyx Biosciences Oral TYK2 Inhibitor Introduction
11.9.4 Ventyx Biosciences Revenue in Oral TYK2 Inhibitor Business (2019-2024)
11.9.5 Ventyx Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Oral TYK2 Inhibitor Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Single-target Inhibitor
Table 3. Key Players of Dual-target Inhibitor
Table 4. Global Oral TYK2 Inhibitor Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Oral TYK2 Inhibitor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Oral TYK2 Inhibitor Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Oral TYK2 Inhibitor Market Share by Region (2019-2024)
Table 8. Global Oral TYK2 Inhibitor Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Oral TYK2 Inhibitor Market Share by Region (2025-2030)
Table 10. Oral TYK2 Inhibitor Market Trends
Table 11. Oral TYK2 Inhibitor Market Drivers
Table 12. Oral TYK2 Inhibitor Market Challenges
Table 13. Oral TYK2 Inhibitor Market Restraints
Table 14. Global Oral TYK2 Inhibitor Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Oral TYK2 Inhibitor Market Share by Players (2019-2024)
Table 16. Global Top Oral TYK2 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral TYK2 Inhibitor as of 2023)
Table 17. Ranking of Global Top Oral TYK2 Inhibitor Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Oral TYK2 Inhibitor Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oral TYK2 Inhibitor Product Solution and Service
Table 21. Date of Enter into Oral TYK2 Inhibitor Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oral TYK2 Inhibitor Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Oral TYK2 Inhibitor Revenue Market Share by Type (2019-2024)
Table 25. Global Oral TYK2 Inhibitor Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Oral TYK2 Inhibitor Revenue Market Share by Type (2025-2030)
Table 27. Global Oral TYK2 Inhibitor Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Oral TYK2 Inhibitor Revenue Market Share by Application (2019-2024)
Table 29. Global Oral TYK2 Inhibitor Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Oral TYK2 Inhibitor Revenue Market Share by Application (2025-2030)
Table 31. North America Oral TYK2 Inhibitor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Oral TYK2 Inhibitor Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Oral TYK2 Inhibitor Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Oral TYK2 Inhibitor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Oral TYK2 Inhibitor Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Oral TYK2 Inhibitor Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Oral TYK2 Inhibitor Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Oral TYK2 Inhibitor Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Oral TYK2 Inhibitor Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral TYK2 Inhibitor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Oral TYK2 Inhibitor Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Oral TYK2 Inhibitor Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Oral TYK2 Inhibitor Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Oral TYK2 Inhibitor Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Oral TYK2 Inhibitor Market Size by Country (2025-2030) & (US$ Million)
Table 46. Bristol-Myers Squibb Company Detail
Table 47. Bristol-Myers Squibb Business Overview
Table 48. Bristol-Myers Squibb Oral TYK2 Inhibitor Product
Table 49. Bristol-Myers Squibb Revenue in Oral TYK2 Inhibitor Business (2019-2024) & (US$ Million)
Table 50. Bristol-Myers Squibb Recent Development
Table 51. InnoCare Pharma Company Detail
Table 52. InnoCare Pharma Business Overview
Table 53. InnoCare Pharma Oral TYK2 Inhibitor Product
Table 54. InnoCare Pharma Revenue in Oral TYK2 Inhibitor Business (2019-2024) & (US$ Million)
Table 55. InnoCare Pharma Recent Development
Table 56. Takeda (Nimbus Therapeutics) Company Detail
Table 57. Takeda (Nimbus Therapeutics) Business Overview
Table 58. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitor Product
Table 59. Takeda (Nimbus Therapeutics) Revenue in Oral TYK2 Inhibitor Business (2019-2024) & (US$ Million)
Table 60. Takeda (Nimbus Therapeutics) Recent Development
Table 61. E-nitiate Biopharmaceuticals Company Detail
Table 62. E-nitiate Biopharmaceuticals Business Overview
Table 63. E-nitiate Biopharmaceuticals Oral TYK2 Inhibitor Product
Table 64. E-nitiate Biopharmaceuticals Revenue in Oral TYK2 Inhibitor Business (2019-2024) & (US$ Million)
Table 65. E-nitiate Biopharmaceuticals Recent Development
Table 66. Highlightll Pharmaceutical Company Detail
Table 67. Highlightll Pharmaceutical Business Overview
Table 68. Highlightll Pharmaceutical Oral TYK2 Inhibitor Product
Table 69. Highlightll Pharmaceutical Revenue in Oral TYK2 Inhibitor Business (2019-2024) & (US$ Million)
Table 70. Highlightll Pharmaceutical Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Oral TYK2 Inhibitor Product
Table 74. Pfizer Revenue in Oral TYK2 Inhibitor Business (2019-2024) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Alumis Inc. Company Detail
Table 77. Alumis Inc. Business Overview
Table 78. Alumis Inc. Oral TYK2 Inhibitor Product
Table 79. Alumis Inc. Revenue in Oral TYK2 Inhibitor Business (2019-2024) & (US$ Million)
Table 80. Alumis Inc. Recent Development
Table 81. Galapagos NV Company Detail
Table 82. Galapagos NV Business Overview
Table 83. Galapagos NV Oral TYK2 Inhibitor Product
Table 84. Galapagos NV Revenue in Oral TYK2 Inhibitor Business (2019-2024) & (US$ Million)
Table 85. Galapagos NV Recent Development
Table 86. Ventyx Biosciences Company Detail
Table 87. Ventyx Biosciences Business Overview
Table 88. Ventyx Biosciences Oral TYK2 Inhibitor Product
Table 89. Ventyx Biosciences Revenue in Oral TYK2 Inhibitor Business (2019-2024) & (US$ Million)
Table 90. Ventyx Biosciences Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral TYK2 Inhibitor Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Oral TYK2 Inhibitor Market Share by Type: 2023 VS 2030
Figure 3. Single-target Inhibitor Features
Figure 4. Dual-target Inhibitor Features
Figure 5. Global Oral TYK2 Inhibitor Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Oral TYK2 Inhibitor Market Share by Application: 2023 VS 2030
Figure 7. Psoriasis Case Studies
Figure 8. Atopic Dermatitis Case Studies
Figure 9. Other Case Studies
Figure 10. Oral TYK2 Inhibitor Report Years Considered
Figure 11. Global Oral TYK2 Inhibitor Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Oral TYK2 Inhibitor Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Oral TYK2 Inhibitor Market Share by Region: 2023 VS 2030
Figure 14. Global Oral TYK2 Inhibitor Market Share by Players in 2023
Figure 15. Global Top Oral TYK2 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral TYK2 Inhibitor as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Oral TYK2 Inhibitor Revenue in 2023
Figure 17. North America Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Oral TYK2 Inhibitor Market Share by Country (2019-2030)
Figure 19. United States Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Oral TYK2 Inhibitor Market Share by Country (2019-2030)
Figure 23. Germany Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Oral TYK2 Inhibitor Market Share by Region (2019-2030)
Figure 31. China Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Oral TYK2 Inhibitor Market Share by Country (2019-2030)
Figure 39. Mexico Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Oral TYK2 Inhibitor Market Share by Country (2019-2030)
Figure 43. Turkey Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Oral TYK2 Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Bristol-Myers Squibb Revenue Growth Rate in Oral TYK2 Inhibitor Business (2019-2024)
Figure 46. InnoCare Pharma Revenue Growth Rate in Oral TYK2 Inhibitor Business (2019-2024)
Figure 47. Takeda (Nimbus Therapeutics) Revenue Growth Rate in Oral TYK2 Inhibitor Business (2019-2024)
Figure 48. E-nitiate Biopharmaceuticals Revenue Growth Rate in Oral TYK2 Inhibitor Business (2019-2024)
Figure 49. Highlightll Pharmaceutical Revenue Growth Rate in Oral TYK2 Inhibitor Business (2019-2024)
Figure 50. Pfizer Revenue Growth Rate in Oral TYK2 Inhibitor Business (2019-2024)
Figure 51. Alumis Inc. Revenue Growth Rate in Oral TYK2 Inhibitor Business (2019-2024)
Figure 52. Galapagos NV Revenue Growth Rate in Oral TYK2 Inhibitor Business (2019-2024)
Figure 53. Ventyx Biosciences Revenue Growth Rate in Oral TYK2 Inhibitor Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
